These studies further suggest that blockade of hB7-1:p75NTR interaction represents a potential therapeutic strategy for inflammatory neuropathologies and neurodegenerative conditions such as MS, AD, and similar pathologies. This evidence concerns the gene NGFR and myeloid sarcoma.